The Toxicology Research Laboratory, a GLP operated, AAALAC Intl.-accredited facility, is an independent contract research unit located within the Department of Pharmacology at the University of Illinois at Chicago (UIC). The Laboratory has conducted numerous preclinical toxicology programs on potential therapeutic agents and other chemicals. Entities such as the National Cancer Institute, the World Health Organization, the U.S Army Medical Research and Development Command, and several biotechnology, pharmaceutical, and agricultural companies utilize the expertise and commitment of the interdisciplinary Toxicology Research Laboratory team. TRL’s genomic and proteomic research is supported by the UIC Genomic core facility and Protein Research Laboratory. TRL is located in the middle of the “Illinois Medical District”, surrounded by four major hospitals. This gives TRL a unique opportunity to continue preclinical safety studies in clinical trials. By offering the resources of a major State University and UIC Hospital with wide experience of staff, professors, and other leading medical specialists, TRL can propose an endless variety of disease models and conduct preclinical studies seamlessly followed by clinical trials to evaluate potential drugs for their cure. General Clinical Research Center supports all clinical trials at UIC. The Toxicology Research Laboratory takes pride in providing individualized service to clients, with sensitivity to specialized needs of various business environments. We are equipped and ready to help meet exact specifications by providing custom-tailored protocols in addition to the conduct of routine safety and efficacy studies. We offer the resources of a major university, while remaining an independent contract research facility. This allows us to provide our clients the best of both worlds - the expertise of a knowledgeable and well-trained team with a focus on client service and responsiveness.